The Preventive and Therapeutic Effects of Intravenous Human Adipose-Derived Stem Cells in Alzheimer's Disease Mice

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kim, Saeromi ^a   Chang, Keun A ^a,d   Kim, Jeong a ^a   Park, Hyeong Geun ^b   Ra, Jeong Chan ^b   Kim, Hye Sun ^a   Suh, Yoo Hun ^a,c  

^a Seoul National University   (South Korea)

^b Stem Cell Research Center   (South Korea)

^c Korea Brain Research Institute (KBRI)   (South Korea)

^d Gachon University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CELL MIGRATION; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; STEM CELL TRANSPLANTATION; TASK PERFORMANCE; UPREGULATION; WESTERN BLOTTING;

ADIPOSE TISSUE; ALZHEIMER DISEASE; AMYLOIDOGENIC PROTEINS; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; TIME FACTORS; TISSUE THERAPY; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84866862490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045757     Document Type: Article

References (41)

1. 2010 Alzheimer's disease facts and figures. Alzheimers Dement 6: 158-194.
2. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, et al. (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106: 13594-13599.
3. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM, (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24: 1063-1070.
4. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, et al. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374: 647-650.
5. Ebert AD, Beres AJ, Barber AE, Svendsen CN, (2008) Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol 209: 213-223.
6. Lu P, Jones LL, Snyder EY, Tuszynski MH, (2003) Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181: 115-129.
7. Park KI, Himes BT, Stieg PE, Tessler A, Fischer I, et al. (2006) Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol 199: 179-190.
8. Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, et al. (2010) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28: 329-343.
9. Anghileri E, Marconi S, Pignatelli A, Cifelli P, Galie M, et al. (2008) Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev 17: 909-916.
10. Huang T, He D, Kleiner G, Kuluz J, (2007) Neuron-like differentiation of adipose-derived stem cells from infant piglets in vitro. J Spinal Cord Med 30 (Suppl 1): S35-40.
11. Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, et al. (2011) Safety of Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Animals and Humans. Stem cells and development.
12. Lee ST, Chu K, Jung KH, Im WS, Park JE, et al. (2009) Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol 66: 671-681.
13. Bhang SH, Cho SW, Lim JM, Kang JM, Lee TJ, et al. (2009) Locally delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs. Stem Cells 27: 1976-1986.
14. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, et al. (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087-1093.
15. Lee E, Son H, (2009) Adult hippocampal neurogenesis and related neurotrophic factors. BMB reports 42: 239-244.
16. Hockfield S, McKay RD, (1985) Identification of major cell classes in the developing mammalian nervous system. J Neurosci 5: 3310-3328.
17. Cho KO, Hunt CA, Kennedy MB, (1992) The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 9: 929-942.
18. Maletic-Savatic M, Malinow R, Svoboda K, (1999) Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 283: 1923-1927.
19. Ikegaya Y, Kim JA, Baba M, Iwatsubo T, Nishiyama N, et al. (2001) Rapid and reversible changes in dendrite morphology and synaptic efficacy following NMDA receptor activation: implication for a cellular defense against excitotoxicity. Journal of cell science 114: 4083-4093.
20. Selkoe DJ, (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766.
21. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, et al. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84.
22. Lesne S, Kotilinek L, (2005) Amyloid plaques and amyloid-beta oligomers: an ongoing debate. J Neurosci 25: 9319-9320.
23. Heese K, Low JW, Inoue N, (2006) Nerve growth factor, neural stem cells and Alzheimer's disease. Neurosignals 15: 1-12.
24. Gimble JM, (2003) Adipose tissue-derived therapeutics. Expert Opin Biol Ther 3: 705-713.
25. Dezawa M, Takahashi I, Esaki M, Takano M, Sawada H, (2001) Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci 14: 1771-1776.
26. Enzmann GU, Benton RL, Talbott JF, Cao Q, Whittemore SR, (2006) Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma 23: 479-495.
27. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
28. Kalbermatten DF, Schaakxs D, Kingham PJ, Wiberg M, (2011) Neurotrophic activity of human adipose stem cells isolated from deep and superficial layers of abdominal fat. Cell Tissue Res 344: 251-260.
29. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-1298.
30. Jeynes B, Provias J, (2011) The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease. J Neurosci Res 89: 22-28.
31. Lee HJ, Lee JK, Lee H, Shin JW, Carter JE, et al. (2010) The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett 481: 30-35.
32. Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, et al. (2007) Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci 27: 11925-11933.
33. Martino G, Pluchino S, (2006) The therapeutic potential of neural stem cells. Nat Rev Neurosci 7: 395-406.
34. Bao X, Wei J, Feng M, Lu S, Li G, et al. (2011) Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 1367: 103-113.
35. Liu N, Chen R, Du H, Wang J, Zhang Y, et al. (2009) Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol Immunol 6: 207-213.
36. Mathieu P, Battista D, Depino A, Roca V, Graciarena M, et al. (2010) The more you have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain. J Neurochem 112: 1368-1385.
37. Carpentier PA, Palmer TD, (2009) Immune influence on adult neural stem cell regulation and function. Neuron 64: 79-92.
38. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P, (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 89: 607-648.
39. Yang SH, Park MJ, Yoon IH, Kim SY, Hong SH, et al. (2009) Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp Mol Med 41: 315-324.
40. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, et al. (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21: 372-381.
41. Ha TY, Chang KA, Kim J, Kim HS, Kim S, et al. (2010) S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS One 5: e8840.